Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

Amikacin concentrations and target ranges for mycobacterial infection

Cairney, Tamara M and Bao, Lock and Robb, Fiona and Thomson, Alison H (2016) Amikacin concentrations and target ranges for mycobacterial infection. In: Federation of Infection Societies/Healthcare Infection Society, 2016-11-05 - 2016-11-07, Edinburgh International Conference Centre.

Text (Cairney-etal-FIS-2016-Amikacin-concentrations-and-target-ranges-for-mycobacterial)
Accepted Author Manuscript

Download (454kB)| Preview


    The aim of this research is to determine whether amikacin dosage guidelines for multi - drug resistant mycobacterial infections achieve peaks of 35 - 45 mg/L (OD) or 65 - 80 mg/L (TW) and troughs <5 mg/L.